Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 4.92% is 181% above its 5-year average of -6.04%, near the high end of its 5-year range (-18.50%–6.54%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.65% above its 12-month average of 3.38%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 4.92%.
RETURN ON INVESTED CAPITAL (ROIC)
4.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
3.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-7.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-6.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-9.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-10.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+45.65%
CURRENT VS 3Y AVG
+170.30%
CURRENT VS 5Y AVG
+181.44%
CURRENT VS 10Y AVG
+151.37%
CURRENT VS 15Y AVG
+147.76%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
+114.68%
vs the sector median at left
OptimizeRx Corp.
Market Cap
$167.32M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
3.38%
3Y Avg
-7.00%
5Y Avg
-6.04%
Market Cap
$169.21M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$164.64M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-23.18%
3Y Avg
-21.02%
5Y Avg
-18.22%
Market Cap
$164.54M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$163.12M
Return on Invested Capital (ROIC)
-57.59%
TTM Avg
-65.44%
3Y Avg
-58.20%
5Y Avg
-45.38%
Market Cap
$172.45M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$172.78M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-29.16%
3Y Avg
-30.37%
5Y Avg
-28.38%
Market Cap
$173.23M
Return on Invested Capital (ROIC)
-42.61%
TTM Avg
-32.20%
3Y Avg
-32.84%
5Y Avg
-32.70%
Market Cap
$174.58M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $167.32M | 4.92% | 3.38% | -7.00% | -6.04% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | -8.34% | 4.10% | 3.63% | 7.54% |
| Quanterix Corporation (QTRX)vs › | $164.64M | -49.08% | -23.18% | -21.02% | -18.22% |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | -135.38% | -110.80% | -91.23% | -65.73% |
| PepGen Inc. (PEPG)vs › | $163.12M | -57.59% | -65.44% | -58.20% | -45.38% |
| MediWound Ltd. (MDWD)vs › | $172.45M | -58.55% | -41.33% | -32.67% | -48.97% |
| Nkarta, Inc. (NKTX)vs › | $172.78M | -42.11% | -29.16% | -30.37% | -28.38% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -42.61% | -32.20% | -32.84% | -32.70% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.58M | -30.23% | -28.70% | -31.34% | -41.69% |
| Cue Biopharma, Inc. (CUE)vs › | $175.51M | -1039.56% | -137.05% | -111.74% | -93.55% |
ROIC
4.9%
ROE
3.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 4.92% |
| 2026-03-31 | 6.54% |
| 2025-12-31 | 5.57% |
| 2025-09-30 | 2.40% |
| 2025-06-30 | -2.54% |
| 2025-03-31 | -7.07% |
| 2024-12-31 | -8.87% |
| 2024-09-30 | -18.50% |
| 2024-06-30 | -14.41% |
| 2024-03-31 | -14.92% |
| 2023-12-31 | -15.74% |
| 2023-09-30 | -14.05% |
| 2023-06-30 | -14.28% |
| 2023-03-31 | -12.57% |
| 2022-12-31 | -9.73% |
| 2022-09-30 | -8.33% |
| 2022-06-30 | -4.97% |
| 2022-03-31 | -2.10% |
| 2021-12-31 | 0.27% |
| 2021-09-30 | 0.86% |
| 2021-06-30 | 0.71% |
| 2021-03-31 | -0.42% |
| 2020-12-31 | -4.25% |
| 2020-09-30 | -12.35% |
| 2020-06-30 | -17.36% |
| 2020-03-31 | -13.01% |
| 2019-12-31 | -7.31% |
| 2019-09-30 | -3.48% |
| 2019-06-30 | 1.61% |
| 2019-03-31 | 2.35% |
| 2018-12-31 | 0.87% |
| 2018-09-30 | 0.39% |
| 2018-06-30 | -4.98% |
| 2018-03-31 | -20.94% |
| 2017-12-31 | -34.24% |
| 2017-09-30 | -37.32% |
| 2017-06-30 | -29.03% |
| 2017-03-31 | -29.89% |
| 2016-12-31 | -20.24% |
| 2016-09-30 | -20.27% |
| 2016-06-30 | -15.85% |
| 2016-03-31 | -9.92% |
| 2015-12-31 | -6.68% |
| 2015-09-30 | -1.16% |
| 2015-06-30 | -12.53% |
| 2015-03-31 | -10.58% |
| 2014-12-31 | -22.26% |
| 2014-09-30 | -23.60% |
| 2014-06-30 | -15.47% |
| 2014-03-31 | -7.23% |
| 2013-12-31 | 10.56% |
| 2013-09-30 | 18.33% |
| 2013-06-30 | 14.68% |
| 2013-03-31 | -12.10% |
| 2012-12-31 | -24.36% |
| 2012-09-30 | -95.78% |
| 2012-06-30 | -105.18% |
| 2012-03-31 | -119.24% |
| 2011-12-31 | -91.49% |
| 2011-09-30 | -45.20% |
| 2011-06-30 | -46.86% |
| 2011-03-31 | -61.96% |
| 2010-12-31 | -63.80% |
| 2010-09-30 | -142.78% |
| 2010-06-30 | -112.35% |
| 2010-03-31 | -247.67% |
| 2009-12-31 | -310.57% |
| 2009-09-30 | -284.54% |
| 2009-06-30 | -199.24% |
| 2009-03-31 | -151.68% |
| 2008-12-31 | -62.45% |
